We want to highlight the fruitful collaborations in the cluster. In a new article series, we present members who have a cluster story to tell. This week, we meet LINK Medical.
Novartis joins the IMPRESS oncology study with six of its cancer medicines to treat up to one hundred patients.
Five new partners have joined CONNECT.
Eva S. Dugstad is our new research and industry facilitator aka competence broker for Oslo-based companies.
Office spaces have transformed into laboratories in Oslo Cancer Cluster Incubator.
ICCS 2021 highlighted success stories and promising newcomers in oncology innovation.